advertisement
Viola F 21
Showing records 1 to 21 | Display all abstracts from Viola F98041 Effect of COVID-19-related lockdown on ophthalmic practice in Italy: A report from 39 institutional centers
dell'Omo R
European Journal of Ophthalmology 2022; 32: 695-703
98867 Dexamethasone Implant for Diabetic Macular Oedema: 1-Year Treatment Outcomes from the Fight Retinal Blindness! Registry
Bhandari S; Gabrielle PH
Ophthalmology and therapy 2022; 11: 797-810
98041 Effect of COVID-19-related lockdown on ophthalmic practice in Italy: A report from 39 institutional centers
Filippelli M
European Journal of Ophthalmology 2022; 32: 695-703
98867 Dexamethasone Implant for Diabetic Macular Oedema: 1-Year Treatment Outcomes from the Fight Retinal Blindness! Registry
Nguyen V
Ophthalmology and therapy 2022; 11: 797-810
98041 Effect of COVID-19-related lockdown on ophthalmic practice in Italy: A report from 39 institutional centers
Virgili G; Bandello F
European Journal of Ophthalmology 2022; 32: 695-703
98867 Dexamethasone Implant for Diabetic Macular Oedema: 1-Year Treatment Outcomes from the Fight Retinal Blindness! Registry
Daien V
Ophthalmology and therapy 2022; 11: 797-810
98041 Effect of COVID-19-related lockdown on ophthalmic practice in Italy: A report from 39 institutional centers
Querques G
European Journal of Ophthalmology 2022; 32: 695-703
98867 Dexamethasone Implant for Diabetic Macular Oedema: 1-Year Treatment Outcomes from the Fight Retinal Blindness! Registry
Viola F; Viola F
Ophthalmology and therapy 2022; 11: 797-810
98041 Effect of COVID-19-related lockdown on ophthalmic practice in Italy: A report from 39 institutional centers
Lanzetta P
European Journal of Ophthalmology 2022; 32: 695-703
98867 Dexamethasone Implant for Diabetic Macular Oedema: 1-Year Treatment Outcomes from the Fight Retinal Blindness! Registry
Bougamha W; Young S
Ophthalmology and therapy 2022; 11: 797-810
98041 Effect of COVID-19-related lockdown on ophthalmic practice in Italy: A report from 39 institutional centers
Avitabile T
European Journal of Ophthalmology 2022; 32: 695-703
98867 Dexamethasone Implant for Diabetic Macular Oedema: 1-Year Treatment Outcomes from the Fight Retinal Blindness! Registry
Romero-Nuñez B
Ophthalmology and therapy 2022; 11: 797-810
98041 Effect of COVID-19-related lockdown on ophthalmic practice in Italy: A report from 39 institutional centers
Viola F; Viola F
European Journal of Ophthalmology 2022; 32: 695-703
98867 Dexamethasone Implant for Diabetic Macular Oedema: 1-Year Treatment Outcomes from the Fight Retinal Blindness! Registry
Figueras-Roca M
Ophthalmology and therapy 2022; 11: 797-810
98041 Effect of COVID-19-related lockdown on ophthalmic practice in Italy: A report from 39 institutional centers
Reibaldi M; Semeraro F
European Journal of Ophthalmology 2022; 32: 695-703
98867 Dexamethasone Implant for Diabetic Macular Oedema: 1-Year Treatment Outcomes from the Fight Retinal Blindness! Registry
Zarranz-Ventura J; Barthelmes D
Ophthalmology and therapy 2022; 11: 797-810
98041 Effect of COVID-19-related lockdown on ophthalmic practice in Italy: A report from 39 institutional centers
Quaranta L; Rizzo S
European Journal of Ophthalmology 2022; 32: 695-703
98867 Dexamethasone Implant for Diabetic Macular Oedema: 1-Year Treatment Outcomes from the Fight Retinal Blindness! Registry
Sararols L
Ophthalmology and therapy 2022; 11: 797-810
98041 Effect of COVID-19-related lockdown on ophthalmic practice in Italy: A report from 39 institutional centers
Midena E
European Journal of Ophthalmology 2022; 32: 695-703
98867 Dexamethasone Implant for Diabetic Macular Oedema: 1-Year Treatment Outcomes from the Fight Retinal Blindness! Registry
Gillies M; Creuzot-Garcher C
Ophthalmology and therapy 2022; 11: 797-810
98041 Effect of COVID-19-related lockdown on ophthalmic practice in Italy: A report from 39 institutional centers
Campagna G; Costagliola C;
European Journal of Ophthalmology 2022; 32: 695-703